• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羽扇豆醇作用机制及其对多重耐药肠球菌临床分离株生物膜的抑制活性。

Mechanism of Action and Biofilm Inhibitory Activity of Lupinifolin Against Multidrug-Resistant Enterococcal Clinical Isolates.

机构信息

Department of Microbiology, Faculty of Science, Prince of Songkhla University, Hat Yai, Thailand.

Excellence Research Laboratory on Natural Products, Faculty of Science, Prince of Songkla University, Hat Yai, Thailand.

出版信息

Microb Drug Resist. 2019 Dec;25(10):1391-1400. doi: 10.1089/mdr.2018.0391. Epub 2019 Jul 16.

DOI:10.1089/mdr.2018.0391
PMID:31314663
Abstract

The treatment of enterococcal infections is becoming more difficult because of multidrug resistance (MDR). Lupinifolin, a prenylated flavonoid isolated from Benth., showed a potent antimicrobial activity against enterococci. The aim of this study was to investigate antibacterial activity and action of lupinifolin against MDR enterococcal clinical isolates. Antibacterial properties of lupinifolin against 21 MDR isolates were assessed using broth microdilution method and time-kill assay. To study mode of action of lupinifolin on the isolates, propidium iodide intensity, salt tolerance assay, and electron microscopic analyses were performed. Antibiofilm formation activity of lupinifolin was conducted using crytal violet assay. Minimal inhibitory concentration (MIC) and minimal bactericidal concentration values of lupinifolin against the isolates ranged between 0.5 and 2.0 μg/mL and between 2 and 16 μg/mL, respectively. Lupinifolin at 2MIC and 4MIC inhibited the bacterial growth >2 log colony-forming units (CFU)/mL at 2 hr incubation by time-kill analysis. The compound increased membrane permeability and caused loss of salt tolerance. SEM and TEM micrographs revealed pronounced morphological and ultrastructural changes in the treated bacteria. Crystal violet staining showed the antibiofilm-producing activity of lupinifolin against four MDR enterococci. This study suggested that lupinifolin is an essential antimicrobial agent that could be useful for the treatment of MDR enterococcal infections.

摘要

由于耐多药(MDR)问题,肠球菌感染的治疗变得越来越困难。从 Benth. 中分离得到的一种被prenylated 的类黄酮 lupinifolin 对肠球菌具有很强的抗菌活性。本研究旨在研究 lupinifolin 对 MDR 肠球菌临床分离株的抗菌活性和作用机制。采用肉汤微量稀释法和时间杀伤试验评估 lupinifolin 对 21 株 MDR 分离株的抗菌特性。为了研究 lupinifolin 对分离株的作用机制,进行了碘化丙啶强度、耐盐性试验和电子显微镜分析。采用结晶紫测定法研究 lupinifolin 的抗生物膜形成活性。lupinifolin 对分离株的最小抑菌浓度(MIC)和最小杀菌浓度值范围分别为 0.5 至 2.0μg/mL 和 2 至 16μg/mL。时间杀伤分析显示,lupinifolin 在 2MIC 和 4MIC 浓度下,在 2 小时孵育时可抑制细菌生长>2 对数菌落形成单位(CFU)/mL。该化合物增加了细胞膜通透性并导致耐盐性丧失。SEM 和 TEM 显微照片显示,经处理的细菌形态和超微结构发生明显变化。结晶紫染色显示 lupinifolin 对四种 MDR 肠球菌具有抗生物膜生成活性。本研究表明,lupinifolin 是一种重要的抗菌剂,可用于治疗 MDR 肠球菌感染。

相似文献

1
Mechanism of Action and Biofilm Inhibitory Activity of Lupinifolin Against Multidrug-Resistant Enterococcal Clinical Isolates.羽扇豆醇作用机制及其对多重耐药肠球菌临床分离株生物膜的抑制活性。
Microb Drug Resist. 2019 Dec;25(10):1391-1400. doi: 10.1089/mdr.2018.0391. Epub 2019 Jul 16.
2
Lupinifolin from Albizia myriophylla wood: A study on its antibacterial mechanisms against cariogenic Streptococcus mutans.合欢木卢比辛醇:抗致龋变形链球菌的抗菌机制研究。
Arch Oral Biol. 2018 Sep;93:195-202. doi: 10.1016/j.archoralbio.2017.10.013. Epub 2017 Oct 18.
3
Phenotypic and genotypic study of biofilm formation in Enterococci isolated from urinary tract infections.从尿路感染中分离出的肠球菌生物膜形成的表型和基因型研究。
Microb Pathog. 2017 Jul;108:85-90. doi: 10.1016/j.micpath.2017.05.014. Epub 2017 May 5.
4
In vitro antibacterial activity of panduratin A against enterococci clinical isolates. panduratin A 对肠球菌临床分离株的体外抗菌活性。
Biol Pharm Bull. 2010;33(9):1489-93. doi: 10.1248/bpb.33.1489.
5
Effect of tedizolid on clinical Enterococcus isolates: in vitro activity, distribution of virulence factor, resistance genes and multilocus sequence typing.替加环素对临床分离肠球菌的影响:体外活性、毒力因子分布、耐药基因及多位点序列分型
FEMS Microbiol Lett. 2018 Feb 1;365(3). doi: 10.1093/femsle/fnx284.
6
Measurement of ampicillin, vancomycin, linezolid and gentamicin activity against enterococcal biofilms.氨苄西林、万古霉素、利奈唑胺和庆大霉素对肠球菌生物膜活性的测定。
J Antimicrob Chemother. 2006 Apr;57(4):767-70. doi: 10.1093/jac/dkl013. Epub 2006 Feb 7.
7
Dalbavancin is active in vitro against biofilms formed by dalbavancin-susceptible enterococci.达巴万星在体外对由对达巴万星敏感的肠球菌形成的生物膜具有活性。
Diagn Microbiol Infect Dis. 2018 Jan;90(1):58-63. doi: 10.1016/j.diagmicrobio.2017.09.015. Epub 2017 Sep 27.
8
Virulence factors, biofilm formation and antibiotic resistance pattern in Enterococcus faecalis and Enterococcus faecium isolated from clinical and commensal human samples in Isfahan, Iran.从伊朗伊斯法罕的临床和共生人体样本中分离出的粪肠球菌和屎肠球菌的毒力因子、生物膜形成及抗生素耐药模式
Ann Ig. 2019 Mar-Apr;31(2):154-164. doi: 10.7416/ai.2019.2268.
9
Occurrence of Enterococcus faecalis and Enterococcus faecium in Various Clinical Infections: Detection of Their Drug Resistance and Virulence Determinants.粪肠球菌和屎肠球菌在各种临床感染中的发生情况:检测它们的耐药性和毒力决定因素。
Microb Drug Resist. 2018 Jan/Feb;24(1):76-82. doi: 10.1089/mdr.2017.0049. Epub 2017 May 19.
10
Detection of oxazolidinone and phenicol resistant enterococcal isolates from duck feces and carcasses.从鸭粪便和尸体中检测到耐恶唑烷酮和氯霉素的肠球菌分离株。
Int J Food Microbiol. 2019 Mar 16;293:53-59. doi: 10.1016/j.ijfoodmicro.2019.01.002. Epub 2019 Jan 6.

引用本文的文献

1
Antibacterial activity of the endophytic fungal extracts and synergistic effects of combinations of ethylenediaminetetraacetic acid (EDTA) against and .内生真菌提取物的抗菌活性以及乙二胺四乙酸(EDTA)组合对……和……的协同作用。 (注:原文中against后内容不完整)
PeerJ. 2025 Mar 5;13:e19074. doi: 10.7717/peerj.19074. eCollection 2025.
2
Proteomic insights into dual-species biofilm formation of E. coli and E. faecalis on urinary catheters.蛋白质组学对导尿管上大肠杆菌和粪肠球菌双物种生物膜形成的见解。
Sci Rep. 2025 Jan 30;15(1):3739. doi: 10.1038/s41598-024-81953-3.
3
Transient comparison of techniques to counter multi-drug resistant bacteria: prime modules in curation of bacterial infections.
对抗多重耐药菌技术的瞬态比较:细菌感染管理中的主要模块
Front Antibiot. 2024 Jan 26;2:1309107. doi: 10.3389/frabi.2023.1309107. eCollection 2023.
4
Bioactive substance contents and therapeutic potential for skin inflammation of an herbal gel containing and .含 和 的草药凝胶的生物活性物质含量及其治疗皮肤炎症的潜力。
Pharm Biol. 2024 Dec;62(1):648-658. doi: 10.1080/13880209.2024.2385456. Epub 2024 Aug 16.
5
Potential of Flavonoids as Promising Phytotherapeutic Agents to Combat Multidrug-Resistant Infections.类黄酮作为有前途的植物治疗剂对抗多重耐药感染的潜力。
Curr Pharm Biotechnol. 2024;25(13):1664-1692. doi: 10.2174/0113892010271172231108190233.
6
Antimycobacterial Precatorin A Flavonoid Displays Antibiofilm Activity against BCG.抗分枝杆菌前花青素A类黄酮对卡介苗具有抗生物膜活性。
ACS Omega. 2023 Oct 20;8(43):40665-40676. doi: 10.1021/acsomega.3c05703. eCollection 2023 Oct 31.
7
Phytochemistry and pharmacology of natural prenylated flavonoids.天然prenylated 黄酮类化合物的化学和药理学。
Arch Pharm Res. 2023 Apr;46(4):207-272. doi: 10.1007/s12272-023-01443-4. Epub 2023 Apr 14.
8
Success stories of natural product-derived compounds from plants as multidrug resistance modulators in microorganisms.植物源天然产物衍生化合物作为微生物多药耐药性调节剂的成功案例。
RSC Adv. 2023 Mar 8;13(12):7798-7817. doi: 10.1039/d3ra00184a.
9
The Genus (Fabaceae): From the Ethnopharmacology to an Evidence-Based Phytotherapeutic Perspective?豆科植物属:从民族药理学视角到循证植物治疗学视角?
Front Pharmacol. 2021 May 7;12:641225. doi: 10.3389/fphar.2021.641225. eCollection 2021.
10
Targeting the 3CLpro and RdRp of SARS-CoV-2 with phytochemicals from medicinal plants of the Andean Region: molecular docking and molecular dynamics simulations.利用安第斯地区药用植物中的植物化学物质靶向 SARS-CoV-2 的 3CLpro 和 RdRp:分子对接和分子动力学模拟。
J Biomol Struct Dyn. 2022 Mar;40(5):2010-2023. doi: 10.1080/07391102.2020.1835716. Epub 2020 Oct 21.